Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/120816
Título: CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3
Autores/as: Canada-Garcia, JE
Moure, Z
Sola-Campoy, PJ
Delgado-Valverde, M
Cano, ME
Gijon, D
Gonzalez, M
Gracia-Ahufinger, I
Larrosa, N
Mulet, X
Pitart, C
Rivera, A
Bou, G
Calvo, J
Canton, R
Gonzalez-Lopez, JJ
Martinez-Martinez, L
Navarro, F
Oliver Serra, Albert
Palacios-Baena, ZR
Pascual, A
Ruiz-Carrascoso, G
Vila, J
Aracil, B
Perez-Vazquez, M
Oteo-Iglesias, J
Pérez Arellano, José Luis 
GEMARA/GEIRAS-SEIMC/REIPI CARB-ES-19 Study Group
Clasificación UNESCO: 32 Ciencias médicas
320103 Microbiología clínica
Palabras clave: CARB-ES-19 study
Carbapenemases
Whole genome sequencing
Klebsiella pneumoniae
High-risk clones
Fecha de publicación: 2022
Publicación seriada: Frontiers in Microbiology 
Resumen: Objectives: CARB-ES-19 is a comprehensive, multicenter, nationwide study integrating whole-genome sequencing (WGS) in the surveillance of carbapenemase-producing K. pneumoniae (CP-Kpn) and E. coli (CP-Eco) to determine their incidence, geographical distribution, phylogeny, and resistance mechanisms in Spain. Methods: In total, 71 hospitals, representing all 50 Spanish provinces, collected the first 10 isolates per hospital (February to May 2019); CPE isolates were first identified according to EUCAST (meropenem MIC > 0.12 mg/L with immunochromatography, colorimetric tests, carbapenem inactivation, or carbapenem hydrolysis with MALDI-TOF). Prevalence and incidence were calculated according to population denominators. Antibiotic susceptibility testing was performed using the microdilution method (EUCAST). All 403 isolates collected were sequenced for high-resolution single-nucleotide polymorphism (SNP) typing, core genome multilocus sequence typing (cgMLST), and resistome analysis. Results: In total, 377 (93.5%) CP-Kpn and 26 (6.5%) CP-Eco isolates were collected from 62 (87.3%) hospitals in 46 (92%) provinces. CP-Kpn was more prevalent in the blood (5.8%, 50/853) than in the urine (1.4%, 201/14,464). The cumulative incidence for both CP-Kpn and CP-Eco was 0.05 per 100 admitted patients. The main carbapenemase genes identified in CP-Kpn were blaOXA–48 (263/377), blaKPC–3 (62/377), blaVIM–1 (28/377), and blaNDM–1 (12/377). All isolates were susceptible to at least two antibiotics. Interregional dissemination of eight high-risk CP-Kpn clones was detected, mainly ST307/OXA-48 (16.4%), ST11/OXA-48 (16.4%), and ST512-ST258/KPC (13.8%). ST512/KPC and ST15/OXA-48 were the most frequent bacteremia-causative clones. The average number of acquired resistance genes was higher in CP-Kpn (7.9) than in CP-Eco (5.5). Conclusion: This study serves as a first step toward WGS integration in the surveillance of carbapenemase-producing Enterobacterales in Spain. We detected important epidemiological changes, including increased CP-Kpn and CP-Eco prevalence and incidence compared to previous studies, wide interregional dissemination, and increased dissemination of high-risk clones, such as ST307/OXA-48 and ST512/KPC-3.
URI: http://hdl.handle.net/10553/120816
ISSN: 1664-302X
DOI: 10.3389/fmicb.2022.918362
Fuente: Frontiers in microbiology [ISSN 1664-302x], v. 13, 918362, (Junio 2022)
Colección:Artículos
Adobe PDF (3,81 MB)
Vista completa

Citas SCOPUSTM   

27
actualizado el 06-oct-2024

Citas de WEB OF SCIENCETM
Citations

24
actualizado el 06-oct-2024

Visitas

71
actualizado el 05-oct-2024

Descargas

22
actualizado el 05-oct-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.